Published Jun 18, 2026, 8:33 PM ET · Updated 5 months ago · 2 sources

US Starts Section 301 Probe of Germany Over Pharmaceuticals

bloomberg
bloomberg
·
Original Report
INFERY
US Starts Section 301 Probe of Germany Over Pharmaceuticals

The US launched a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.